In the article by Dans et al, “Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial,” which was published in the February 5, 2013 issue of the journal (Circulation. 2013;127:634–640), an error occurred. The “+ anti platelet” and “- anti platelet” legends in figure 3 were reversed.
The correction has been made in the current online version of the manuscript. The authors regret the error.
- © 2013 American Heart Association, Inc.